Description
TE 300 – Testosterone Enanthate 300mg/ml
TE 300 is a long-acting injectable testosterone enanthate formulation dosed at 300mg/ml. Known for its reliable pharmacokinetics and extended half-life of approximately 7–10 days, it provides a steady release of testosterone, maintaining stable hormone levels with minimal injection frequency.
Widely used in both clinical and performance contexts, testosterone enanthate is valued for its ability to support sustained muscle hypertrophy, enhance protein synthesis, improve strength, and accelerate post-exercise recovery. Its androgenic and anabolic profile makes it a key component in any long-term performance-enhancement regimen.
Application:
TE 300 is often employed during bulking cycles or as a testosterone base in multi-compound protocols. It integrates effectively with agents such as Deca 300 or Boldenon 300 for comprehensive anabolic support.
Important Note:
As with all testosterone esters, enanthate suppresses endogenous testosterone production. Post-cycle therapy (PCT) is essential to facilitate hormonal recovery.
All products sold by ORYVION are intended for laboratory research purposes only and are not approved for human consumption, medical use, or veterinary applications. These compounds are not classified as dietary supplements or pharmaceuticals.
ORYVION operates strictly within the legal frameworks of the jurisdictions in which it conducts business. Sales are limited to countries and regions where the possession and use of research chemicals are permitted by law. It is the sole responsibility of the purchaser to ensure compliance with local, national, and international laws and regulations.
By purchasing, the customer affirms that they are at least 21 years of age, legally authorized to receive such materials, and fully aware of their intended use. ORYVION disclaims all liability for misuse, improper handling, or any consequences resulting from non-compliant use of these products.
ORYVION complies with relevant provisions under EU’s Pharmaceutical and Medical Device Act, as well as applicable international guidelines regarding non-pharmaceutical research compounds.